Randal W. Berg

438 total citations
16 papers, 356 citations indexed

About

Randal W. Berg is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Randal W. Berg has authored 16 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology and Allergy. Recurrent topics in Randal W. Berg's work include Colorectal Cancer Treatments and Studies (5 papers), Cell Adhesion Molecules Research (5 papers) and Biochemical and Molecular Research (4 papers). Randal W. Berg is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cell Adhesion Molecules Research (5 papers) and Biochemical and Molecular Research (4 papers). Randal W. Berg collaborates with scholars based in Canada, New Zealand and United States. Randal W. Berg's co-authors include James Koropatnick, Michael W. McBurney, Mark Vincent, Geoffrey W. Krissansen, Klaus Lehnert, Euphemia Leung, Jagat R. Kanwar, Jian Ni, G W Krissansen and Peter J. Ferguson and has published in prestigious journals such as Developmental Biology, Journal of Pharmacology and Experimental Therapeutics and European Journal of Immunology.

In The Last Decade

Randal W. Berg

16 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randal W. Berg Canada 11 249 83 63 36 33 16 356
Elisabeth Coene Belgium 10 218 0.9× 145 1.7× 46 0.7× 71 2.0× 24 0.7× 17 454
Hong Seo Choi South Korea 12 272 1.1× 86 1.0× 60 1.0× 35 1.0× 22 0.7× 24 422
Marie-Chantal Grégoire Canada 12 246 1.0× 121 1.5× 113 1.8× 50 1.4× 21 0.6× 21 469
Anne Jokilammi Finland 10 211 0.8× 60 0.7× 55 0.9× 31 0.9× 14 0.4× 23 321
S. O. Yim United States 9 316 1.3× 163 2.0× 82 1.3× 74 2.1× 24 0.7× 9 496
Tomoko Tsujie Japan 8 153 0.6× 81 1.0× 100 1.6× 24 0.7× 45 1.4× 13 347
Paula Boutin United States 11 216 0.9× 120 1.4× 196 3.1× 19 0.5× 27 0.8× 13 487
E. Seccamani Italy 5 152 0.6× 96 1.2× 70 1.1× 15 0.4× 29 0.9× 9 449
James E. Hayden United States 9 272 1.1× 83 1.0× 37 0.6× 21 0.6× 39 1.2× 11 420
Helicia Paz United States 10 308 1.2× 117 1.4× 102 1.6× 45 1.3× 19 0.6× 12 463

Countries citing papers authored by Randal W. Berg

Since Specialization
Citations

This map shows the geographic impact of Randal W. Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randal W. Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randal W. Berg more than expected).

Fields of papers citing papers by Randal W. Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randal W. Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randal W. Berg. The network helps show where Randal W. Berg may publish in the future.

Co-authorship network of co-authors of Randal W. Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Randal W. Berg. A scholar is included among the top collaborators of Randal W. Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randal W. Berg. Randal W. Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Figueredo, René, et al.. (2008). ODN 491, a Novel Antisense Oligodeoxynucleotide That Targets Thymidylate Synthase, Exerts Cell-Specific Effects in Human Tumor Cell Lines. DNA and Cell Biology. 27(5). 229–240. 4 indexed citations
2.
Pandyra, Aleksandra A., Randal W. Berg, Mark Vincent, & James Koropatnick. (2007). Combination Silencer RNA (siRNA) Targeting Bcl-2 Antagonizes siRNA against Thymidylate Synthase in Human Tumor Cell Lines. Journal of Pharmacology and Experimental Therapeutics. 322(1). 123–132. 8 indexed citations
4.
Berg, Randal W., et al.. (2006). Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma. Molecular Cancer Therapeutics. 5(6). 1423–1433. 20 indexed citations
5.
Koropatnick, James, et al.. (2004). Toxicology of antisense therapeutics. Toxicology and Applied Pharmacology. 201(1). 66–83. 114 indexed citations
6.
Berg, Randal W., Peter J. Ferguson, Mark Vincent, & James Koropatnick. (2003). A “combination oligonucleotide” antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance. Cancer Gene Therapy. 10(4). 278–286. 13 indexed citations
7.
Berg, Randal W., et al.. (2002). The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger. Current Drug Targets. 3(4). 297–309. 16 indexed citations
8.
Kanwar, Jagat R., et al.. (2001). Induction of systemic antitumor immunity by gene transfer of mammalian heat shock protein 70.1 into tumors in situ. Cancer Gene Therapy. 8(12). 974–981. 11 indexed citations
9.
Berg, Randal W., Melanie Werner, Peter J. Ferguson, et al.. (2001). Tumor Growth Inhibition in Vivo and G2/M Cell Cycle Arrest Induced by Antisense Oligodeoxynucleotide Targeting Thymidylate Synthase. Journal of Pharmacology and Experimental Therapeutics. 298(2). 477–484. 17 indexed citations
10.
Kanwar, Jagat R., Randal W. Berg, Klaus Lehnert, & G W Krissansen. (1999). Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity. Gene Therapy. 6(11). 1835–1844. 19 indexed citations
11.
Zhang, Victor Wei, Yi Yang, Randal W. Berg, Euphemia Leung, & Geoffrey W. Krissansen. (1999). The small GTP-binding proteins Rho and Rac induce T cell adhesion to the mucosal addressin MAdCAM-1 in a hierarchical fashion. European Journal of Immunology. 29(9). 2875–2885. 7 indexed citations
13.
Zhang, Victor Wei, Yi Yang, Randal W. Berg, Euphemia Leung, & Geoffrey W. Krissansen. (1999). The small GTP-binding proteins Rho and Rac induce T cell adhesion to the mucosal addressin MAdCAM-1 in a hierarchical fashion. European Journal of Immunology. 29(9). 2875–2885. 1 indexed citations
14.
Berg, Randal W., Yi Yang, Klaus Lehnert, & Geoffrey W. Krissansen. (1999). Mouse M290 is the functional homologue of the human mucosal lymphocyte integrin HML‐1: Antagonism between the integrin ligands E‐cadherin and RGD tripeptide. Immunology and Cell Biology. 77(4). 337–344. 10 indexed citations
15.
Leung, Euphemia, Randal W. Berg, Ries J. Langley, et al.. (1997). Genomic organization, chromosomal mapping, and analysis of the 5' promoter region of the human MAdCAM-1 gene. Immunogenetics. 46(2). 111–119. 13 indexed citations
16.
Berg, Randal W. & Michael W. McBurney. (1990). Cell density and cell cycle effects on retinoic acid-induced embryonal carcinoma cell differentiation. Developmental Biology. 138(1). 123–135. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026